TRICLOSAN (TRİKLOSAN)
EC Number:222-182-2
CAS Number:3380-34-5
SYNONMYS:
2,4,4'-trichloro-2'-hydroxydiphenyl ether; 2-Hydroxy-2',4,4'-trichlorodiphenyl Ether; Aquasept; Clearasil Daily Face Wash; Cliniclean; DP300, Irgasan; Irgasan DP 300; Irgasan DP300; Irgasan-DP300; Manusept; Microshield T; Oxy Skin Wash; pHisoHex; Sapoderm; Ster Zac Bath Concentrate; Ster-Zac Bath Concentrate; SterZac Bath Concentrate; Tersaseptic; Triclosan; Trisan; triclosan; 3380-34-5; 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL; 2,4,4'-Trichloro-2'; hydroxydiphenyl ether; Irgasan; Cloxifenolum; Triclosanum; Irgasan DP300; Stri-Dex Face Wash; Aquasept; Sapoderm; Phenol, 5-chloro-2-(2,4-dichlorophenoxy)- Lexol 300; Stri-Dex Cleansing Bar; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Triclosanum [INN-Latin]; CH 3565; Irgasan DP 300; DP-300; Caswell No. 186A; Cloxifenol; C12H7Cl3O2; Triclosan [USAN:BAN:INN]; UNII-4NM5039Y5X; HSDB 7194; CHEBI:164200; 2-Hydroxy-2',4,4'-trichlorodiphenyl Ether; Triclosan (USP/INN); Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl; Phenyl ether, 2'-hydroxy-2,4,4'-trichloro-; EINECS 222-182-2; IN1424; CHEMBL849; EPA Pesticide Chemical Code; 054901; BRN 2057142; Stri-Dex cleansing bar (TN); 2,4,4'-Trichloro-2'-hydroxy diphenyl ether; XEFQLINVKFYRCS-UHFFFAOYSA-N; 4NM5039Y5X; 88032-08-0; CH-3565 TCL; NCGC00159417-02; NCGC00159417-05; NCGC00159417-06; DSSTox_CID_12498; DSSTox_RID_78958; DSSTox_GSID_32498; Q-201866; Cliniclean; Trisan; Microshield TOxy Skin Wash; 2-(2,4-dichlorophenoxy)-5-chlorophenol; SMR000471847; CAS-3380-34-5; SR-01000762974; SterZac Bath Concentrate; Ster Zac Bath Concentrate; Ster-Zac Bath Concentrate; Trichlorosan; Sterzac; CCRIS 9253; Triclosan USP; 1nhg; Triclosan [USAN:USP:INN:BAN]; Triclosan; Irgasan; Irgasan DP 30; TCCP; Neostrata Antibacterial Facial Cleanser; Triclosan Reckitt Bran; 3p9t; 4w9n; SSL Brand of Triclosan; Clearasil DailyFace Wash; AC1L1KMN; Triclosan Pharmachem; Brand; D00CSQ; D09SNH; Dermtek Brand of Triclosan; Epitope ID:119683; Reckitt Brand of Triclosan; SCHEMBL3269; KSC498G0D; MLS001066347; MLS001074876; MLS001335937;; MLS001335938; Pharmachem Brand of Triclosan; BDBM8726; ZINC2216; DTXSID5032498; CTK3J8301; BII1002; MolPort-003-666-702; Trans Canaderm Brand of Triclosan; ZX-AFC000465; GlaxoSmithKline Brand of Triclosan; HMS2093L17; HMS2270M06; HMS3259K19; HMS3715H11; Pharmakon1600-01505465; trichloro-2'-hydroxydiphenyl ether; Irgasan, >=97.0% (HPLC); DNDI1246774; HY-B1119; KS-000009AG; Tox21_111648; Tox21_400079; ANW-42338; DP 300; GA5716; MFCD00800992; NSC759151; Procter & Gamble Brand of Triclosan; s4541; SBB058565; STL451034; 5-chloro-(2,4-dichlorophenoxy)phenor; AKOS015850380; Tox21_111648_1; API0004498; CCG-213459; CH-3635; CS-4718; DB08604; KS-5356; MCULE-2614621397; NC00516; NSC-759151; RTR-014090; TRA0068104; WL-1001; NCGC00159417-03; NCGC00159417-04; NCGC00159417-07; NCGC00159417-08; AC-10667; AJ-08144; AK-73001; BC678270; BR-73001; CJ-00083; CPD000471847; LS-67854; SAM002554907; SC-16588; ZB000507; 5-chloro-2-(2, 4-dichlorophenoxy)phenol; SBI-0206807.P001; AX8020299; KB-197273; Phenol,5-chloro-2-(2,4-dichlorophenoxy)- ST2411924; TL8002539; TR-014090; 5-chloro-2-(2,4-di-chloro-phenoxy)-phenol; FT-0609773; ST50826110; CH-3565, Lexol 300, Irgasan DP 300; C12059; D06226; J10025; M-6446; S00100; 5-Chloro-2-(2,4-dichlorophenoxy)phenol, 97%; AB00698074_08; Triclosan (Irgasan) 10 microg/mL in Cyclohexane; Triclosan, Antibiotic for Culture Media Use Only; 380T345; A821950; C-18186; 2-[2,4-bis(chloranyl)phenoxy]-5-chloranyl-phenol; I01-2897; SR-01000762974-2; SR-01000762974-3; BRD- K41731458-001-04-5; BRD-K41731458-001-09-4; Triclosan, certified reference material, TraceCERT(R); 5-Chloro-2-(2, 4-dichlorophenoxy) phenol, 99% 25g F2173-0825; Triclosan, United States Pharmacopeia (USP) Reference Standard; Triclosan, Pharmaceutical Secondary Standard; Certified Reference Material; 112099-35-1; 1155174-27-8; 164325-69-3; 261921-78-2; tiriklosan; tiriklozan; triklozan; tiriclosan; tırıclosan; tırıclozan; tiriclosan;
Are There Benefits of Triclosan?
For some consumer products, there is evidence that triclosan provides a benefit. In 1997, FDA reviewed extensive effectiveness data on triclosan in Colgate Total toothpaste. The evidence showed that triclosan in that product was effective in preventing gingivitis.For other products, such as over-the-counter (OTC) consumer antiseptic products, FDA has not received evidence that triclosan provides a benefit to human health. At this time, FDA doesn't have evidence that triclosan in OTC consumer antibacterial soaps and body washes provides any benefit over washing with regular soap and water.In December 2017, the FDA issued a final rule regarding certain OTC health-care antiseptic products. As a result, companies will not be able to use triclosan or 23 other active ingredients in these products without premarket review due to insufficient data regarding their safety and effectiveness.
Triclosan'ın Faydaları Var mı?
Bazı tüketici ürünleri için, triklosanın bir fayda sağladığına dair kanıtlar vardır. 1997 yılında FDA, Colgate Total diş macununda triklosan üzerinde kapsamlı etkililik verilerini gözden geçirdi. Kanıtlar, bu üründe triklosanın dişeti iltihabının önlenmesinde etkili olduğunu gösterdi. Reçetesiz (OTC) tüketici antiseptik ürünleri gibi diğer ürünler için, FDA triklosanın insan sağlığına fayda sağladığına dair bir kanıt elde etmemiştir. Şuanda, FDA, OTC tüketici antibakteriyel sabunlarında ve vücut yıkamalarında triklosanın düzenli sabun ve suyla yıkamanın herhangi bir yararı olduğuna dair kanıtlara sahip değildir. Aralık 2017'de FDA, belirli OTC sağlık bakım ürünü antiseptik ürünlerine ilişkin nihai bir kural yayınladı. Sonuç olarak, şirketler bu ürünlerdeki triklosan veya 23 diğer aktif bileşeni, güvenlik ve etkinliklerine ilişkin yetersiz veriler nedeniyle premarket incelemeden kullanamazlar.